Predictors of Postoperative Delirium After Transcatheter Aortic Valve Implantation
NCT ID: NCT02585128
Last Updated: 2024-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
201 participants
INTERVENTIONAL
2015-09-30
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Acute neurocognitive dysfunctions are associated with adverse outcomes in these population.
The objective of this study is to determine the incidence of delirium and neurocognitive disorders in elderly patients after TAVI.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative BAMCOG and Cortisol and Postoperative DeltaScan in AVR Patients (Aortic Valve Replacement)
NCT05209555
Cognitive Outcome After Surgical and Transcatheter Aortic Valve Replacement
NCT04535076
Impact of Anesthesia Technique on Post-operative Delirium After Transcatheter Aortic Valve Implantation
NCT03323619
Neurocognitive Assessment in TAVI
NCT06120946
Cardiac Output, Cerebral Perfusion and Cognition in Patients Undergoing TAVI
NCT05481008
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients following TAVI
Delirium assessment
During the first post-procedural five days all patients will be evaluated on a daily basis for delirium occurrence by the CAM (Confusion Assessment Method) or CAM - ICU (Confusion Assessment Method - Intensive Care Unit)
MMSE (Mini Mental State Examination)
Barthel index
HADS (Hospital Anxiety and Depression Scale)
MNA-SF (Mini Nutritional Assessment - Short Form)
NIRS (Near-Infrared Spectroscopy)
Regional cerebral oxygen saturation monitoring during TAVI procedure
CIRS (Cumulative Illness Rating Scale)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delirium assessment
During the first post-procedural five days all patients will be evaluated on a daily basis for delirium occurrence by the CAM (Confusion Assessment Method) or CAM - ICU (Confusion Assessment Method - Intensive Care Unit)
MMSE (Mini Mental State Examination)
Barthel index
HADS (Hospital Anxiety and Depression Scale)
MNA-SF (Mini Nutritional Assessment - Short Form)
NIRS (Near-Infrared Spectroscopy)
Regional cerebral oxygen saturation monitoring during TAVI procedure
CIRS (Cumulative Illness Rating Scale)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing transcatheter aortic valve implantation
* Patients have given informed consent for participation at the study
Exclusion Criteria
* Inability to understand the national languages
* Emergency procedures
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cardiocentro Ticino
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tiziano Cassina
Tiziano Cassina, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tiziano Cassina, MD
Role: PRINCIPAL_INVESTIGATOR
Cardiocentro Ticino
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiocentro Ticino
Lugano, Canton Ticino, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DELTAVI-CCT-ICU-2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.